M F Festing|G L Wolff - JoVE Visualize

Showing results (81-90 of 94) with videos related to

Pageof 10

Sort By:

Carcinogenesis|June 1, 1995

DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formationP Carthew, K J Rich, E A Martin, et al.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1994

Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti geneT T Yen, A M Gill, L G Frigeri, et al.

Experimental Lung Research|July 11, 1998

Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) geneL Lin, M F Festing, T R Devereux, et al.

Molecular Carcinogenesis|January 1, 1996

Differential spontaneous transformation in vitro of newly established mouse fibroblast lines carrying or lacking the viable yellow mutation (Avy) of the mouse agouti locusW L Hsiao, G L Wolff, B M North, et al.

Journal of Toxicology and Environmental Health|January 1, 1985

Effects of age and obesity on the metabolism of lindane by black a/a, yellow Avy/a, and pseudoagouti Avy/a phenotypes of (YS x VY) F1 hybrid miceR W Chadwick, M F Copeland, G L Wolff, et al.

Laboratory Animals|July 1, 1976

Rabbit mortality surveyJ C Whitney, D K Blackmore, G H Townsend, et al.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1990

Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c x VY)F1 hybrid miceG L Wolff, D L Greenman, L G Frigeri, et al.

Journal of Toxicology and Environmental Health|January 1, 1987

Saturation of lindane metabolism in chronically treated (YS x VY) F1 hybrid miceR W Chadwick, M F Copeland, G L Wolff, et al.

Carcinogenesis|May 1, 1991

Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid miceG L Wolff, J E Leakey, J J Bazare, et al.

Toxicologic Pathology|January 23, 1998

Genome-linked toxic responses to dietary iron overloadP Whittaker, V C Dunkel, T J Bucci, et al.

Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:

Pageof 10

Carcinogenesis|June 1, 1995

DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formationP Carthew, K J Rich, E A Martin, et al.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|May 1, 1994

Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti geneT T Yen, A M Gill, L G Frigeri, et al.

Experimental Lung Research|July 11, 1998

Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) geneL Lin, M F Festing, T R Devereux, et al.

Molecular Carcinogenesis|January 1, 1996

Differential spontaneous transformation in vitro of newly established mouse fibroblast lines carrying or lacking the viable yellow mutation (Avy) of the mouse agouti locusW L Hsiao, G L Wolff, B M North, et al.

Journal of Toxicology and Environmental Health|January 1, 1985

Effects of age and obesity on the metabolism of lindane by black a/a, yellow Avy/a, and pseudoagouti Avy/a phenotypes of (YS x VY) F1 hybrid miceR W Chadwick, M F Copeland, G L Wolff, et al.

Laboratory Animals|July 1, 1976

Rabbit mortality surveyJ C Whitney, D K Blackmore, G H Townsend, et al.

Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|February 1, 1990

Diabetogenic response to streptozotocin varies among obese yellow and among lean agouti (BALB/c x VY)F1 hybrid miceG L Wolff, D L Greenman, L G Frigeri, et al.

Journal of Toxicology and Environmental Health|January 1, 1987

Saturation of lindane metabolism in chronically treated (YS x VY) F1 hybrid miceR W Chadwick, M F Copeland, G L Wolff, et al.

Carcinogenesis|May 1, 1991

Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid miceG L Wolff, J E Leakey, J J Bazare, et al.

Toxicologic Pathology|January 23, 1998

Genome-linked toxic responses to dietary iron overloadP Whittaker, V C Dunkel, T J Bucci, et al.

Pageof 10